HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PCARE
photoreceptor cilium actin regulator
Chromosome 2 Β· 2p23.2
NCBI Gene: 388939Ensembl: ENSG00000179270.7HGNC: HGNC:34383UniProt: A6NGG8
18PubMed Papers
22Diseases
0Drugs
151Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
ciliumphotoreceptor cell outer segment organizationprotein localization to photoreceptor outer segmentphotoreceptor outer segmentretinitis pigmentosaRetinal dystrophyautosomal recessive retinitis pigmentosaPCARE-related retinopathy
✦AI Summary

PCARE (photoreceptor cilium actin regulator) is an actin-associated protein essential for photoreceptor outer segment (OS) disk formation and maintenance 1. Structurally, PCARE contains a helical coiled coil domain, conserved binding sites for the kinase MAK, and EVH1 domain-binding linear motifs that are critical for its function 2. Functionally, PCARE recruits and activates the Arp2/3 complex activator WASF3 to the ciliary tip, driving actin polymerization and membrane expansion at the base of the photoreceptor OS where new disk formation initiates 1. Loss of PCARE or expression of disease-associated mutations impairs this actin-driven ciliary expansion process 1. PCARE mutations cause severe inherited retinal dystrophies, including retinitis pigmentosa 54 (RP54) and cone-rod dystrophy 23 3. PCARE-associated retinopathy presents as severe generalized photoreceptor dystrophy with macular atrophy in all affected individuals 3. Clinically, patients experience progressive vision loss, with legal blindness occurring at a median age of 57 years, though foveal sparing often preserves central vision into late adulthood 3. The optimal therapeutic window for intervention appears to be before the fifth decade of life 3. Novel PCARE variants continue to expand the phenotypic spectrum, including bilateral macular colobomata 4.

Sources cited
1
PCARE recruits WASF3 to regulate actin-driven expansion of ciliary membrane during photoreceptor OS disk formation initiation
PMID: 32312818
2
PCARE structural domains (coiled coil, MAK kinase-binding, EVH1 domain-binding motifs) are required for ciliary function and localization
PMID: 35253837
3
PCARE-associated retinopathy is a severe generalized photoreceptor dystrophy with macular atrophy; legal blindness occurs at median age 57 years
PMID: 40261664
4
PCARE mutations can present with expanded phenotype including bilateral macular colobomata
PMID: 40400237
5
PCARE contains proline-rich segments that bind to EVH1 domains with physiological ligand interactions
PMID: 39138154
Disease Associationsβ“˜22
retinitis pigmentosaOpen Targets
0.79Strong
Retinal dystrophyOpen Targets
0.57Moderate
autosomal recessive retinitis pigmentosaOpen Targets
0.49Moderate
PCARE-related retinopathyOpen Targets
0.45Moderate
Cone rod dystrophyOpen Targets
0.44Moderate
cone-rod dystrophyOpen Targets
0.43Moderate
Stargardt diseaseOpen Targets
0.35Weak
genetic disorderOpen Targets
0.19Weak
Posterior column ataxia - retinitis pigmentosaOpen Targets
0.17Weak
optic atrophyOpen Targets
0.15Weak
hypertensionOpen Targets
0.12Weak
pyogenic granulomaOpen Targets
0.12Weak
mixed connective tissue diseaseOpen Targets
0.10Weak
Abruptio PlacentaeOpen Targets
0.10Suggestive
gangreneOpen Targets
0.09Suggestive
chronic kidney diseaseOpen Targets
0.07Suggestive
age-related macular degenerationOpen Targets
0.06Suggestive
Familial drusenOpen Targets
0.06Suggestive
X-linked retinal dysplasiaOpen Targets
0.06Suggestive
Familial exudative vitreoretinopathyOpen Targets
0.06Suggestive
Cone-rod dystrophy 23UniProt
Retinitis pigmentosa 54UniProt
Pathogenic Variants151
NM_001029883.3(PCARE):c.2966del (p.Pro989fs)Pathogenic
not provided|Retinal disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 989
NM_001029883.3(PCARE):c.802C>T (p.Gln268Ter)Pathogenic
Retinal dystrophy|Autosomal recessive retinitis pigmentosa|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 268
NM_001029883.3(PCARE):c.3002G>A (p.Trp1001Ter)Pathogenic
Retinitis pigmentosa|not provided|Retinal dystrophy|See cases|Retinitis pigmentosa 54|PCARE-related disorder|Retinal disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 1001
NM_001029883.3(PCARE):c.1525del (p.Thr509fs)Pathogenic
Retinal dystrophy|Autosomal recessive retinitis pigmentosa|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 509
NM_001029883.3(PCARE):c.1273C>T (p.Arg425Ter)Pathogenic
not provided|Retinitis pigmentosa 54
β˜…β˜…β˜†β˜†2025β†’ Residue 425
NM_001029883.3(PCARE):c.3604C>T (p.Arg1202Ter)Pathogenic
not provided|Retinal dystrophy|Retinitis pigmentosa 54|Retinitis pigmentosa with macular involvement
β˜…β˜…β˜†β˜†2025β†’ Residue 1202
NM_001029883.3(PCARE):c.2950C>T (p.Arg984Ter)Pathogenic
Retinitis pigmentosa|not provided|Retinal dystrophy
β˜…β˜…β˜†β˜†2025β†’ Residue 984
NM_001029883.3(PCARE):c.3346_3349del (p.Ser1116fs)Pathogenic
not provided|Retinitis pigmentosa 54
β˜…β˜…β˜†β˜†2025β†’ Residue 1116
NM_001029883.3(PCARE):c.3289C>T (p.Gln1097Ter)Pathogenic
Retinitis pigmentosa|not provided|Retinitis pigmentosa 54
β˜…β˜…β˜†β˜†2025β†’ Residue 1097
NM_001029883.3(PCARE):c.2789_2795dup (p.Gln932fs)Pathogenic
Retinal dystrophy|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 932
NM_001029883.3(PCARE):c.2966dup (p.Val990fs)Pathogenic
not provided|Retinitis pigmentosa 54
β˜…β˜…β˜†β˜†2025β†’ Residue 990
NM_001029883.3(PCARE):c.2159G>A (p.Trp720Ter)Pathogenic
not provided|Retinal dystrophy|Retinitis pigmentosa 54|Retinitis pigmentosa
β˜…β˜…β˜†β˜†2025β†’ Residue 720
NM_001029883.3(PCARE):c.1837C>T (p.Arg613Ter)Pathogenic
not provided|Retinitis pigmentosa 54
β˜…β˜…β˜†β˜†2025β†’ Residue 613
NM_001029883.3(PCARE):c.2967del (p.Val990fs)Pathogenic
Retinitis pigmentosa 54|Autosomal recessive retinitis pigmentosa|PCARE-related disorder
β˜…β˜…β˜†β˜†2024β†’ Residue 990
NM_001029883.3(PCARE):c.3668+2T>CLikely pathogenic
Retinitis pigmentosa 54|Retinal dystrophy
β˜…β˜…β˜†β˜†2024
NM_001029883.3(PCARE):c.2704A>T (p.Lys902Ter)Pathogenic
not provided|Retinitis pigmentosa 54
β˜…β˜…β˜†β˜†2024β†’ Residue 902
NM_001029883.3(PCARE):c.2665dup (p.Leu889fs)Pathogenic
Retinal dystrophy|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 889
NM_001029883.3(PCARE):c.776_777del (p.Glu259fs)Pathogenic
Retinitis pigmentosa|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 259
NM_001029883.3(PCARE):c.402_405del (p.Ser134fs)Pathogenic
Retinal dystrophy|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 134
NM_001029883.3(PCARE):c.3358_3359del (p.His1120fs)Pathogenic
Retinal dystrophy|Retinitis pigmentosa 54
β˜…β˜…β˜†β˜†2023β†’ Residue 1120
View on ClinVar β†—
Related Genes
PDE6BProtein interaction85%ABCA4Protein interaction84%CNGB1Protein interaction84%CNGA1Protein interaction84%GUCA1BProtein interaction84%PDE6AProtein interaction84%
Tissue Expression6 tissues
Heart
100%
Ovary
36%
Lung
7%
Brain
5%
Bone Marrow
1%
Liver
0%
Gene Interaction Network
Click a node to explore
PCAREPDE6BABCA4CNGB1CNGA1GUCA1BPDE6A
PROTEIN STRUCTURE
Preparing viewer…
PDB7LXF Β· 1.65 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.03LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.85 [0.70–1.03]
RankingsWhere PCARE stands among ~20K protein-coding genes
  • #14,767of 20,598
    Most Researched18
  • #504of 5,498
    Most Pathogenic Variants151 Β· top 10%
  • #10,227of 17,882
    Most Constrained (LOEUF)1.03
Genes detectedPCARE
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 20301590
1.00
2
PCARE requires coiled coil, RP62 kinase-binding and EVH1 domain-binding motifs for ciliary expansion.
PMID: 35253837
Hum Mol Genet Β· 2022
0.90
3
An educational model for special patient care in dentistry.
PMID: 37544886
Spec Care Dentist Β· 2023
0.80
4
PCARE and WASF3 regulate ciliary F-actin assembly that is required for the initiation of photoreceptor outer segment disk formation.
PMID: 32312818
Proc Natl Acad Sci U S A Β· 2020
0.70
5
Higher buprenorphine dose associated with increased treatment retention at low threshold buprenorphine clinic: A retrospective cohort study.
PMID: 36804350
J Subst Use Addict Treat Β· 2023
0.60